Awards and Honors

Bristol-Myers Squibb Cancer Research Award Recipients

2001 - V Craig Jordan, PhD, DSc, for research that laid the foundation for the clinical use of antiestrogens and selective estrogen receptor modulators (SERMS -- tamoxifen and raloxifene) for breast cancer. He identified the value of tamoxifen to treat patients with estrogen receptor (ER) positive breast cancer and the strategy to extend adjuvant therapy to five years. He was the first to identify SERM action in bone and breast that has resulted in raloxifene to treat osteoporosis and its testing as a preventive for breast cancer. Dr. Jordan is Vice President and Research Director for the Division of Medical Science and the Alfred G. Knudson Chair of Cancer Research at Fox Chase Cancer Center in Philadelphia.